# Incidence and Predictors of Bleeding During and Following ERCP

> **NCT05929404** · — · COMPLETED · sponsor: **University of Calgary** · enrollment: 5872 (actual)

## Conditions studied

- Bleeding UGI (During or Post-ERCP)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05929404
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-01
- **Primary completion:** 2023-08-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 5872 (ACTUAL)
- **Last updated:** 2024-01-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05929404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05929404, "Incidence and Predictors of Bleeding During and Following ERCP". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05929404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*